After administering oral doses of calcitriol and calcium carbonate to a client with hypoparathyroidism, the nurse notes that the client's total calcium level is 14 mg/dL (3.5 mmol/L). Which action should the nurse implement?

Choice A reason: Confirming that the daughter is aware of the progressive nature of the disease is not the best response, as it does not address the daughter's misconception about the drug. The nurse should educate the daughter that rivastigmine does not cure or stop the progression of Alzheimer's disease, but only slows down the cognitive decline.

Choice B reason: Affirming the decision to use the medication when the symptoms start to worsen is not appropriate, as it contradicts the evidence-based practice. The nurse should inform the daughter that rivastigmine is most effective when used in the early stages of Alzheimer's disease, as it can delay the need for institutionalization and improve the quality of life.

Choice C reason: Explaining that the drug should be used early in the course of the disease process is the best response, as it corrects the daughter's misunderstanding and provides accurate information. The nurse should explain that rivastigmine works by inhibiting the enzyme that breaks down acetylcholine, a neurotransmitter that is involved in memory and learning. By increasing the level of acetylcholine in the brain, rivastigmine can improve the cognitive function and behavior of the client.

Choice D reason: Assessing the client's current mental status before deciding to support the decision is not relevant, as it does not address the daughter's concern or the rationale for the drug. The nurse should already have the client's baseline mental status from the initial assessment and diagnosis. The nurse should focus on educating the daughter about the benefits and risks of rivastigmine and encouraging her to follow the prescribed regimen.

Choice A reason: Employed as a construction worker is not the most important assessment finding for the nurse to address. Although the client's occupation may expose them to moist and warm environments that can promote fungal growth, it is not directly related to the administration of terbinafine HCL. The nurse should advise the client to wear breathable shoes and socks and keep the feet dry and clean, but it is not a priority.

Choice B reason: Reported history of alcoholism is the most important assessment finding for the nurse to address. Terbinafine HCL can cause hepatotoxicity, especially in clients with pre-existing liver disease or who consume alcohol regularly. The nurse should assess the client's liver function tests and alcohol intake before starting the medication and inform the prescriber accordingly. The nurse should also monitor the client for signs and symptoms of liver damage, such as jaundice, abdominal pain, nausea, or fatigue.

Choice C reason: White blood cell count of 8,500/mm3 (8.5 x 10^9/L) is not the most important assessment finding for the nurse to address. This value is within the normal reference range of 5,000 to 10,000/mm3 (5 to 10 x 10^9/L) and does not indicate any infection or inflammation. The nurse should check the client's baseline blood counts before starting the medication, but it is not a priority.

Choice D reason: Toenails appear thick and yellow is not the most important assessment finding for the nurse to address. This is a typical manifestation of a fungal toenail infection, which is the indication for terbinafine HCL. The nurse should expect the toenails to improve in appearance and texture after the completion of the treatment, which may take several weeks or months. The nurse should educate the client about the expected outcomes and adherence to the medication regimen, but it is not a priority.